Suppr超能文献

高分辨率熔解分析(HRM)在甲状腺发育不良患者中 Dnajc17 基因突变筛查中的应用。

High-resolution melting analysis (HRM) for mutational screening of Dnajc17 gene in patients affected by thyroid dysgenesis.

机构信息

Dipartimento di Medicina Clinica e Chirurgia, Università degli Studi di Napoli "Federico II", Via S. Pansini, 5, 80131, Naples, Italy.

TIGEM, Via Campi Flegrei 34, 80078, Pozzuoli, NA, Italy.

出版信息

J Endocrinol Invest. 2018 Jun;41(6):711-717. doi: 10.1007/s40618-017-0795-7. Epub 2017 Nov 20.

Abstract

BACKGROUND

Congenital hypothyroidism is a frequent disease occurring with an incidence of about 1/1500 newborns/year. In about 75% of the cases, CH is caused by alterations in thyroid morphogenesis, defined "thyroid dysgenesis" (TD). TD is generally a sporadic disease but in about 5% of the cases a genetic origin has been demonstrated. Previous studies indicate that Dnajc17 as a candidate modifier gene for hypothyroidism, since it is expressed in the thyroid bud, interacts with NKX2.1 and PAX8 and it has been associated to the hypothyroid phenotype in mice carrying a single Nkx2.1 and Pax8 genes (double heterozygous knock-out).

PURPOSE

The work evaluates the possible involvement of DNAJC17 in the pathogenesis of TD.

METHODS

High-resolution DNA melting analysis (HRM) and direct sequencing have been used to screen for mutations in the DNAJC17 coding sequence in 89 patients with TD.

RESULTS

Two mutations have been identified in the coding sequence of DNAJC17 gene, one in exon 5 (c.350A>C; rs79709714) and one in exon 9 (c.610G>C; rs117485355). The last one is a rare variant, while the rs79709714 is a polymorphism. Both are present in databases and the frequency of the alleles is not different between TD patients and controls.

CONCLUSIONS

DNAJC17 mutations are not frequently present in patients with TD.

摘要

背景

先天性甲状腺功能减退症是一种常见疾病,发病率约为 1/1500 名新生儿/年。在大约 75%的病例中,CH 是由甲状腺形态发生的改变引起的,定义为“甲状腺发育不良”(TD)。TD 通常是一种散发性疾病,但在大约 5%的病例中,已经证明了遗传起源。先前的研究表明,Dnajc17 作为甲状腺功能减退症的候选修饰基因,因为它在甲状腺芽中表达,与 NKX2.1 和 PAX8 相互作用,并与携带单个 Nkx2.1 和 Pax8 基因(双杂合敲除)的小鼠的甲状腺功能减退表型相关。

目的

本研究评估了 DNAJC17 基因在 TD 发病机制中的可能作用。

方法

使用高分辨率 DNA 熔解分析(HRM)和直接测序技术对 89 例 TD 患者的 DNAJC17 编码序列进行突变筛查。

结果

在 DNAJC17 基因的编码序列中发现了两个突变,一个在exon 5(c.350A>C;rs79709714),一个在 exon 9(c.610G>C;rs117485355)。后者是一种罕见的变异,而 rs79709714 是一种多态性。这两种变异都存在于数据库中,等位基因的频率在 TD 患者和对照组之间没有差异。

结论

TD 患者中 DNAJC17 基因突变并不常见。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验